Browse by ▼

Nu Skin Enterprises, Inc.

  • Hey Musclehead! 2 Reasons to Buy GNC Holdings

    By Robert Baillieul - May 17, 2013 | Tickers: GNC, NUS, VSI

    In the middle of a roaring bull market, finding great companies trading at reasonable prices becomes challenging. Top quality names are bid up and investors turn to second and third-rate stocks while hunting for value. 

    Fortunately, there're still some high-caliber plays that haven't run up with the rest of the market. GNC Holdings (NYSE: GNC) is one example. The company is best of breed in the fast growing more »

  • Herbalife Short Insanely Stupid: Don't Join In

    By Alexander Cho - May 8, 2013 | Tickers: AVP, HLF, NUS

    Herbalife (NYSE: HLF) has been receiving a lot of scrutiny from investors lately. This is partially driven by the declining stock value, due in part to investor Bill Ackman’s billion dollar short against the stock. I believe there are some key issues with Bill Ackman’s bet against Herbalife.

    Some pyramid schemes are sustainable

    One of the favorite arguments a Multi-Level-Marketing (MLM) promoter will use to defend the pyramid more »

  • The "Pyramid" Scheme Continues To Outperform

    By Callum Turcan - May 6, 2013 | Tickers: HLF, JCP, NUS, USNA

    The company accused of being one large fraud continues to outperform and reward shareholders in the long run. Embattled Herbalife (NYSE: HLF) has been fighting with Bill Ackman over whether or not it is a pyramid scheme. Considering that Herbalife as been operating in the U.S. since 1980, let's assume that they are at least somewhat legal (at the very least) and that it is worth looking at more »

  • The Return of Herbalife

    By Shazir Mucklai - April 10, 2013 | Tickers: AVP, HLF, NUS

    Herbalife (NYSE: HLF) has picked up a bunch of traction in the news lately with tons of people shorting it and tons of people buying into it. Recently, this stock picked up a ton of volume after billionaire investor Bill Ackman said this stock was a pyramid scheme, and was the worst investment idea he has ever seen, in terms of keeping it as long term stock. After he said more »

  • The Return of Herbalife

    By Shazir Mucklai - March 28, 2013 | Tickers: AVP, HLF, NUS

    Herbalife (NYSE: HLF) has picked up a bunch of traction in the news lately with tons of people shorting it and tons of people buying into it. Recently, this stock picked up a ton of volume after billionaire investor Bill Ackman said this stock was a pyramid scheme, and was the worst investment idea he has ever seen, in terms of keeping it as long term stock. After he said more »

  • What to Make of Direct Selling?

    By Piyush Arora - March 27, 2013 | Tickers: AVP, HLF, NUS

    The billionaire showdown is almost resonant to the Herbalife (NYSE: HLF) fiasco that unfolded over the last couple of months. Bill Ackman still remains convinced that Herbalife’s business model is unsustainable, while Carl Icahn believes the contrary. Whether Herbalife survives or not is another topic for debate, but I’m confident that for its part, Nu Skin Enterprises (NYSE: NUS) has been beaten down for no reason and investors more »

  • A Huge Insider Buy of This Nutritional Product Direct Seller

    By Anh HOANG - March 16, 2013 | Tickers: HLF, NATR, NUS

    When looking for investment opportunities, I often take a close look at stocks with recent huge insider purchases. When insiders are getting bullish about their company, it implies that they think their company’s stock will rise in the near future. Recently, an independent director of Nature’s Sunshine Products (NASDAQ: NATR), Mr. Williem Mesdag has bought nearly 367,500 shares of the company at an average price of $14 more »

  • Should You Join the Health-and-Wellness Craze?

    By Robert Ciura - March 6, 2013 | Tickers: GNC, HLF, NUS

    One of the most interesting and provocative bits of market news is the battle Herbalife (NYSE: HLF) is currently embroiled in. As many market observers probably know, Herbalife happens to be the subject of a bitter brawl between two of Wall Street’s most famous investors, Bill Ackman and Carl Icahn. Each has taken an opposite view on Herbalife, with Ackman calling the company’s legitimacy into question. Herbalife is more »

  • Reasons You Should Believe in Herbalife

    By Josef Ray Dagatan - February 28, 2013 | Tickers: AVP, HLF, NUS

    Herbalife (NYSE: HLF) is synonymous to a selling strategy called multi-level marketing (MLM,) or direct selling. Some argue that this MLM is a good way to start an entrepreneurial path with very minimum capital involved. On the other hand, some call MLM a bad idea, and may even be tagged as a form of pyramid scheme. Whatever the case, Herbalife continues to grow despite these challenges and the criticism thrown more »

  • All Gussied up and No Place to Go

    By Diane Alter - February 28, 2013 | Tickers: AVP, NUS, PG

    Following six consecutive quarters of ugly earnings, cosmetic company Avon Products (NYSE: AVP) finally posted better than expected sales and earnings for Q4 and the full year of 2012. In fact, the 37 cents adjusted earnings per share the company posted for the fourth quarter handily beat the consensus forecast of 27 cents, and full year earnings of 85 cents came in ahead of the estimated 76 cents.

    But despite more »

  • The Battle of Hedge Funds

    By Callum Turcan - February 22, 2013 | Tickers: HLF, NUS

    On January 25, Carl Icahn and Bill Ackman dueled on CNBC over an MLM (multi-level marketing) company called Herbalife (NYSE: HLF). Bill contests that Herbalife is a pyramid scheme and is shorting about 20% of its stock ($1 billion), saying that the fair value of Herbalife is zero. Carl came out and recently bought a 12.98% stake in Herbalife, saying that Bill was pulling an "Ackman Scheme." Carl states more »

  • One Multi Level Marketer Is On A Tear

    By Marshall Hargrave - February 21, 2013 | Tickers: AVP, NUS, REV, EL

    Despite the turmoil surrounding multi-level marketing companies, with billionaire Bill Ackman launching an offensive against Herbalife, Avon (NYSE: AVP) saw its stock up 20% after its earnings announcement. Avon investors took the numbers as “stabilizing” and a sign that restructuring might be taking hold for the company, but is it too rich for investors to buy in now? I wouldn't go that far (read more about the earnings over more »

  • Five Noteworthy Dividend Increases for Friday

    By Brian Nichols - February 15, 2013 | Tickers: NHI, NUS, OXY, PPL, VTR

    In an economy where companies operate with record amounts of cash on their balance sheet and are slow to return capital to shareholders, it is always encouraging to see a company give back. As a result, I am looking at five companies that announced an increase in dividend on Friday or after the market closed on Thursday. These are high-yield stocks that might fit well into your portfolio.

    Overvalued but more »

  • Herbalife - To Buy or Not to Buy?

    By Anh HOANG - February 11, 2013 | Tickers: HLF, MED, NUS

    Over the past three decades, Herbalife (NYSE: HLF) has been one of the fastest growing multilevel-marketing companies. However, it has recently been attacked by Bill Ackman, one of the most famous hedge fund activist investors. With a $0 target price for Herbalife, Ackman considered this to be the highest conviction that he had ever had about any of his investments. In contrast, Dan Loeb, another famous hedge fund manager, viewed more »

  • The Fortune Hi-Tech Lawsuit May Actually Help Herbalife

    By Bob Chandler - February 5, 2013 | Tickers: HLF, MED, NUS, TUP

    The turmoil surrounding Herbalife (NYSE: HLF), a health products multi-level marketing company, seems to get increasingly interesting. First, there was the on-air verbal joust between celebrated investor Carl Icahn and hedge fund manager Bill Ackman. Then, it was reported that at the request of the Federal Trade Commission (FTC) and three states, a federal court halted an allegedly illegal pyramid scheme. The case alleges that multi-level marketing (M-L-M) company, Fortune more »

  • High Short Float but Cheaply Valued

    By Anh HOANG - February 4, 2013 | Tickers: BTH, HLF, NUS, USNA

    “Be fearful when others are greedy, be greedy when others are fearful” 

    Warren Buffett

    That is the key to wealth. When good stocks with high insider ownership are on sale, investors should bet on them. In order to find such opportunities, I create a simple stock screen with four main criteria: (1) market capitalization is greater than $100 million, (2) short float is more than 25%, (3) insider ownership is more »

  • Don't Let the Fear Hold You Back

    By Neha Gupta - February 1, 2013 | Tickers: CHD, HLF, NUS

    It has been a topsy turvy ride for the shares of Herbalife (NYSE: HLF) over the last one year. After hitting an all-time high of $73 in April, the stock has seen a 50% correction. Initially, it was a speculation that David Einhorn had shorted Herbalife (based on some questions he asked on the company's 1Q earnings conference call) that sent the company’s stock plummeting more than 20 more »

  • Should You Believe Ackman or Icahn?

    By Zain Abbas - January 29, 2013 | Tickers: CHD, HLF, NUS

    Herbalife (NYSE: HLF), the marketing company that sells nutritional supplements, has recently been having an extremely bumpy ride, after mega-investor, Bill Ackman of Pershing Square, disclosed that his fund had shorted 20% of this company’s total float. From my perspective, Herbalife’s management gave a superb presentation in response that calmed the nerves of its investors.

    However, the recent announcement that FTC has seized the assets of a multi-level more »

  • Herbalife, Loeb, and Ackman: What to Do?

    By Nate Wooley - January 22, 2013 | Tickers: AVP, HLF, NATR, NUS

    Direct selling companies have always had a strange, ill-defined place in the markets. They don't meet typical expectations for a company, yet somehow they're always out there. Throw in that often you'll find that a social connection, a friend, or family member, will suddenly become a commercial connection through selling some form of direct sales products and the discomfort grows.

    Still, many of them seem to do more »

  • Strong Post-Earning Performers that Could Continue to Perform

    By Brian Nichols - January 18, 2013 | Tickers: ASML, BLK, FAST, NUS

    Citigroup, Bank of America, and eBay were the most highly anticipated earnings yesterday, but none of these was the most impressive -- there were several other companies that truly set themselves apart. In this article I am looking at several of these companies, and what it could mean for their stock.

    ASML Holding (NASDAQ: ASML)

    In my opinion, ASML Holding provided us with one of the best quarters of the day more »

  • Page 1 of 3